ADMA vs GEN · P/E 22, rev $426.5M vs P/E 17, rev $5.00B
ADMA Biologics Inc (ADMA) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the ADMA and GEN stock pages for the full models.
Not investment advice.